PharmEasy investor cuts value of its stake drastically, implying new valuation of $456M

Indian online pharmacy PharmEasy is now being valued at about $456 million after its investor Janus Henderson said in a filing that it valued its stake of 12.9 million shares in the startup at $766,043. The asset manager’s Global Research Fund had originally spent $9.4 million to acquire these shares. This valuation is 92% less […]
© 2024 TechCrunch. All rights reserved. For personal use only.